|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 508.00 CHF | -1.28% |
|
-5.37% | -5.65% |
| 04/03 | Octane Biotech Inc. agreed to acquire Personalized Medicine business from Lonza Group AG. | CI |
| 25/02 | Iconovo AB (Publ.) and Lonza Signs LOI Regarding Strategic Collaboration | CI |
| Capitalization | 3.61TCr 4.61TCr 3.99TCr 3.47TCr 6.33TCr 4,23800Cr 6.61TCr 43TCr 17TCr 2,03100Cr 17TCr 17TCr 7,28100Cr | P/E ratio 2025 |
39.8x | P/E ratio 2026 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise value | 3.96TCr 5.06TCr 4.37TCr 3.8TCr 6.93TCr 4,64400Cr 7.24TCr 47TCr 19TCr 2,22500Cr 19TCr 19TCr 7,97900Cr | EV / Sales 2025 |
6.28x | EV / Sales 2026 * | 5.43x |
| Free-Float |
93.86% | Yield 2025 |
0.93% | Yield 2026 * | 1.06% |
Last Transcript: Lonza Group AG
| 1 day | -1.44% | ||
| 1 week | -5.37% | ||
| Current month | -5.37% | ||
| 1 month | -1.89% | ||
| 3 months | -7.51% | ||
| 6 months | -11.01% | ||
| Current year | -5.65% |
| 1 week | 506.6 | 535.4 | |
| 1 month | 498 | 542.4 | |
| Current year | 498 | 585.6 | |
| 1 year | 467.8 | 605.2 | |
| 3 years | 308.6 | 616 | |
| 5 years | 308.6 | 785.4 | |
| 10 years | 151.7 | 785.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wolfgang Wienand
CEO | Chief Executive Officer | 54 | 01/07/2024 |
Philippe Deecke
DFI | Director of Finance/CFO | 54 | 01/12/2021 |
Daniel Buchta
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 65 | 16/04/2014 |
| Director/Board Member | 68 | 16/04/2014 | |
Christoph Mäder
BRD | Director/Board Member | 66 | 26/04/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.52% | -5.37% | -11.08% | -10.04% | 4.61TCr | ||
| -2.03% | -9.13% | +11.72% | +21.39% | 3.25TCr | ||
| +7.14% | -12.60% | +19.09% | +53.36% | 3.12TCr | ||
| +0.35% | +4.61% | -3.95% | -19.16% | 3TCr | ||
| -1.53% | -2.46% | +151.49% | +291.51% | 1.97TCr | ||
| -1.67% | +3.65% | +52.28% | +107.98% | 1.46TCr | ||
| -0.97% | -4.55% | +25.79% | +4.77% | 1.34TCr | ||
| +0.76% | +4.99% | +42.86% | +134.94% | 1.33TCr | ||
| -5.40% | -6.75% | +122.70% | +105.36% | 1.24TCr | ||
| -4.87% | -7.91% | +21,691.18% | +3,407.17% | 1.2TCr | ||
| Average | -0.59% | -2.97% | +2,210.21% | +409.73% | 2.25TCr | |
| Weighted average by Cap. | +0.18% | -3.63% | +1,182.18% | +233.62% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 756.68Cr 966.24Cr 835.61Cr 726.46Cr 1.32TCr 89TCr 1.38TCr 8.95TCr 3.58TCr 43TCr 3.63TCr 3.55TCr 1,52400Cr | 725.74Cr 926.74Cr 801.45Cr 696.76Cr 1.27TCr 85TCr 1.33TCr 8.59TCr 3.43TCr 41TCr 3.48TCr 3.4TCr 1,46200Cr |
| Net income | 102.65Cr 131.08Cr 113.36Cr 99Cr 179.75Cr 12TCr 187.67Cr 1.21TCr 485.29Cr 5.77TCr 491.98Cr 481.46Cr 21TCr | 116.91Cr 149.29Cr 129.11Cr 112.24Cr 204.71Cr 14TCr 213.74Cr 1.38TCr 552.7Cr 6.57TCr 560.31Cr 548.34Cr 24TCr |
| Net Debt | 346.31Cr 442.23Cr 382.44Cr 332.48Cr 606.41Cr 41TCr 633.13Cr 4.1TCr 1.64TCr 19TCr 1.66TCr 1.62TCr 70TCr | 325.11Cr 415.16Cr 359.03Cr 312.13Cr 569.29Cr 38TCr 594.38Cr 3.85TCr 1.54TCr 18TCr 1.56TCr 1.52TCr 66TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | 507.00 CHF | -1.48% | 51,567 |
| 05/26/05 | 514.60 CHF | -2.09% | 1,31,092 |
| 04/26/04 | 525.60 CHF | +1.43% | 1,04,411 |
| 03/26/03 | 518.20 CHF | -2.26% | 1,55,266 |
| 02/26/02 | 530.20 CHF | -1.12% | 1,60,199 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LONN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















